After-Hours Movers 7/28: IRBT, WIRE, ITRI, PCCC, CML, SKX, OII, ENTR, LMAT Higher; VPRT, CVD, CTV, ARRS, SYMC, LOGM, NVDA, AKAM Lower
Vistaprint N.V. (Nasdaq: VPRT) 25% LOWER; reports Q4 adj-EPS of $0.38, 1 cent better than the analyst estimate of $0.37. Revenue for the quarter was $164.3 million, which compares to the estimate of $168.79 million. Sees Q1 EPS of $0.27-$0.32 on sales of $159-$165 million. Sees FY10 sales of $750-$780 million on EPS of $2.09-$2.24.
Covance (NYSE: CVD) 14.8% LOWER; reports Q2 EPS of $0.49, even with the analyst estimate of $0.49. Revenue for the quarter was $475 million, which compares to the estimate of $478.06. Lower FY10 Outlook. Revenue growth now 2% - 4%, and an EPS lowered from $2.40 - $2.65 to $2.10 - $2.30. EPS consensus is $2.45.
IRobot (Nasdaq: IRBT) 11.5% HIGHER; reports Q2 EPS of $0.20, 14 cents better than the analyst estimate of $0.06. Revenue for the quarter was $98 million, which compares to the estimate of $92.19 million. Sees Q3 EPS of $0.05 - $0.06, versus $0.07 consensus. Raises FY10 EPS from $0.35 - $0.40 to $0.51 - $0.54, versus the consensus of $0.44.
Commscope (NYSE: CTV) 11.1% LOWER; reports Q2 EPS of $0.55, 1 cent better than the analyst estimate of $0.54. Revenue for the quarter was $838 million, which compares to the estimate of $828.55 million. Sees Q3 sales of $815-$865 million, vs. the cons. of $869.7 million.
Arris (Nasdaq: ARRS) 10% LOWER; reports Q2 adjusted EPS of $0.24, versus the analyst estimate of $0.25. Revenue for the quarter was $280.4 million, which compares to the estimate of $288.27 million. Sees Q3 EPS of $0.16 - $0.20, versus $0.27 consensus. Sees Q3 sales $270 - $290 million, versus $300.5 million consensus.
Encore Wire (Nasdaq: WIRE) 9.1% HIGHER; reports Q2 EPS of $0.35, 23 cents better than the analyst estimate of $0.12. Revenue for the quarter was $236.1 million, which compares to the estimate of $180.07 million.
Itron (Nasdaq: ITRI) 8.8% HIGHER; reports Q2 non-GAAP EPS of $0.98, versus the analyst estimate of $0.73. Revenue for the quarter was $569 million, which compares to the estimate of $499.94 million.
PC Connection (Nasdaq: PCCC) 8.5% HIGHER; reports Q2 EPS of $0.18, 6 cents better than the analyst estimate of $0.12. Revenue for the quarter was $477.5 million, which compares to the estimate of $449.85 million.
Compellent Technologies (NYSE: CML) 8.3% HIGHER; reports Q2 EPS of $0.04, 3 cents better than the analyst estimate of $0.01. Revenue for the quarter was $36.5 million, which compares to the estimate of $33.85 million.
Skechers USA (NYSE: SKX) 8.1% HIGHER; reports Q2 EPS of $0.82, versus the analyst estimate of $0.44. Revenue for the quarter was $504.9 million, which compares to the estimate of $427.79 million.
Symantec (Nasdaq: SYMC) 7.8% LOWER; reports Q1 EPS of $0.35, in-line the analyst estimate of $0.35. Revenue for the quarter was $1.43 billion, which compares to the estimate of $1.47 billion. Q2 sale $1.445-$1.465, versus the consensus of $ 1.53 billion. Sees Q2 EPS of $0.27-$0.28, versus the consensus of $0.34.
Oceaneering International (NYSE: OII) 7.5% HIGHER; reports Q2 EPS of $0.98, versus the analyst estimate of $0.81. Revenue for the quarter was $464 million, which compares to the estimate of $455.28 million. Sees Q3 EPS of $0.90 - $1.00, compared to the consensus of $0.72.
LogMeIn (Nasdaq: LOGM) 7.5% LOWER; reports Q2 adjusted EPS of $0.20, 3 cents better than the analyst estimate of $0.17. Revenue for the quarter was $23.5 million, which compares to the estimate of $22.62 million.
NVIDIA Corporation (Nasdaq: NVDA) 6.5% LOWER; lowers Q2 sales guidance from $950-970 to $800-$820 million and the consensus of $955 million.
Akamai Technologies (Nasdaq: AKAM) 6.5% LOWER; reports Q2 EPS of $0.34, ex-items, inline with the analyst estimate of $0.34. Revenue for the quarter was $245.3 million, which compares to the estimate of $243.27 million.
Entropic Communications (Nasdaq: ENTR) 6% HIGHER; reports Q2 EPS of $0.08, 1 cent better than the analyst estimate of $0.07. Revenue for the quarter was $40.7 million, which compares to the estimate of $39.65 million.
LeMaitre Vascular, Inc. (Nasdaq: LMAT) 6% HIGHER; reports Q2 EPS of $0.09, cents better than the analyst estimate of $0.06. Revenue for the quarter was $14.2 million, which compares to the estimate of $ million. Increases stock buyback by $5 million. Sees Q3 sales of about $13.8 million, versus $13.7 million consensus. Raises FY10 sales from about $55 million to $55.8 million, versus $54.7 million consensus.
LSI Logic (NYSE: LSI) 6% LOWER; reports Q2 EPS of $0.11, in-line analyst estimate of $0.11. Revenue for the quarter was $639 million, which compares to the estimate of $654.44 million. Sees Q3 EPS of $0.08-$0.14, versus $0.13. Sees sales of 625-$655 million versus $694.9 million.
SourceFire (Nasdaq: FIRE) 5.5% HIGHER; reports Q2 EPS of $0.11, ex-items, 2 cents better than the analyst estimate of $0.09. Revenue for the quarter was $30.6 million, which compares to the estimate of $28.17 million. Sees Q3 adj-EPS of $0.13-$0.15, vs. the consensus of $0.14. Sees sales of $34.4-$34.8 million, vs. cons. of $34.47 million.
Citrix Systems (Nasdaq: CTXS) 5% HIGHER; reports Q2 EPS of $0.41, versus the analyst estimate of $0.45. Revenue for the quarter was $458 million, which compares to the estimate of $436.94 million. Sees Q3 EPS of $0.48 - $0.49, versus $0.48 consensus. Also sees Q3 sales of $450 - $460 million, versus $446 million consensus.
Concur Technologies (Nasdaq: CNQR) 4.9% LOWER; reports Q3 EPS of $0.19, 1 cent better than the analyst estimate of $0.18. Revenue for the quarter was $75 million, which compares to the estimate of $74.19 million.
Digital River (Nasdaq: DRIV) 4% LOWER; reports Q2 adjusted EPS of $0.08, 3 cents better than the analyst estimate of $0.05. Revenue for the quarter was $81.8 million, which compares to the estimate of $82.03 million. Sees Q3 EPS of about 0.13, versus $0.14 consensus. Sales about $77.6 million, versus the consensus of $81.2 million.
China BAK Battery, Inc. (Nasdaq: CBAK) 3.9% HIGHER; reports Q2 adj-loss of $0.06, versus the analyst estimate of ($0.01). Revenue for the quarter was $58.6 million, which compares to the estimate of $58.6 million.
Genzyme (Nasdaq: GENZ) 3.7% HIGHER; Sanofi (NYSE: SNY) Board said to support a Genzyme bid of up to $70/share.
FalconStor Software (Nasdaq: FALC) 3.7% HIGHER; reports Q2 adjusted loss of $0.04, 3 cents better than the analyst estimate of ($0.07). Revenue for the quarter was $20.3 million, which compares to the estimate of $17.94 million.
CardioNet (Nasdaq: BEAT) 3.7% LOWER; reports Q2 loss of ($0.02), 8 cents better than the analyst estimate of ($0.10). Revenue for the quarter was $31.9 million, which compares to the estimate of $33.50 million.
Express Scripts (Nasdaq: ESRX) 3.5% LOWER; reports Q2 adjusted EPS of $0.60, 1 cent better than the analyst estimate of $0.59. Revenue for the quarter was $11.3 billion, which compares to the estimate of $11.25 billion. Reaffirms outlook.
NetLogic (Nasdaq: NETL) 3% LOWER; reports Q2 EPS of $0.38, 6 cents better than the analyst estimate of $0.32. Revenue for the quarter was $95 million, which compares to the estimate of $95.10 million.
Flowserve (NYSE: FLS) 2.9% LOWER; reports Q2 EPS of $1.72, 7 cents lower than the analyst estimate of $1.65. Revenue for the quarter was $961.1 million, which compares to the estimate of $1.00 billion.
Charles & Colvard Ltd. (Nasdaq: CTHR) 2.5% HIGHER; reports Q2 EPS of $0.02, versus ($0.07) reported for the same period a year ago. Revenue for the quarter was $3.33 million, compared to $1.32 million in Q209.
DryShips (Nasdaq: DRYS) 2.3% HIGHER; reports Q2 adjusted EPS of $0.30, 8 cents better than the analyst estimate of $0.22. Revenue for the quarter was $207.5 million, which compares to the estimate of $216.17 million.
Nu Skin (NYSE: NUS) 2.2% HIGHER; reports Q2 EPS of $0.50, 4 cents better than the analyst estimate of $0.46. Revenue for the quarter was $388.4 million, which compares to the estimate of $369.74 million. Sees Q3 EPS of $0.45 - $0.48, versus $0.45. Raises FY10 outlook from $1.80 - $1.88 to $1.90 - $1.96, versus $1.89 consensus.
PSS World Medical (Nasdaq: PSSI) 2.2% LOWER; reports Q1 EPS of $0.24, 2 cents lower than the analyst estimate of $0.26. Revenue for the quarter was $478.9 million, which compares to the estimate of $499.58 million. Reaffirms guidance.
AstraZeneca PLC (NYSE: AZN) 2.1% HIGHER; wins FDA backing of Brilinta for heart attacks
ManTech (Nasdaq: MANT) 2.1% LOWER; reports Q2 EPS of $0.88, 4 cents better than the analyst estimate of $0.84. Revenue for the quarter was $661.6 million, which compares to the estimate of $674.53 million. Sees FY10 EPS $3.36 - $3.48, versus $3.44 consensus. Also sees FY10 sales of $2.63 - $2.75 billion, versus $2.7 billion consensus.
Cerner (Nasdaq: CERN) 2% LOWER; reports Q2 EPS of $0.69, 1 cent better than the analyst estimate of $0.68. Revenue for the quarter was $456 million, which compares to the estimate of $449.33 million. Sees Q3 sales of $455 - $470 million, versus $465 million consensus. Raises FY10 EPS to $2.85 - $2.92, versus $2.88 consensus. Raises FY10 sales outlook to $1.83 - $1.875 billion, versus $1.85 billion.
Lincoln National (NYSE: LNC) 1.9% HIGHER; reports Q2 EPS of $0.86, 10 cents better than the analyst estimate of $0.76. Revenue for the quarter was $2.6 billion, which compares to the estimate of $2.59 billion.
Walter Energy, Inc. (NYSE: WLT) 1.9% LOWER; reports Q2 EPS of $2.16, versus the analyst estimate of $1.93. Revenue for the quarter was $410.6 million, which compares to the estimate of $409.09 million.
TriQuint Semiconductor (Nasdaq: TQNT) 1.7% LOWER; reports Q2 EPS of $0.20, ex-items, 5 cents better than the analyst estimate of $0.15. Revenue for the quarter was $207.5 million, which compares to the estimate of $205.90 million. Sees Q3 EPS of about $0.20, vs. the cons. of $0.18, on sales of $215-$225 million, which compares to the STreet estimate of $217.2 million.
Huron Consulting (Nasdaq: HURN) 1.6% LOWER; reports Q2 EPS of $0.45, ex-items, 9 cents better than the analyst estimate of $0.36. Revenue for the quarter was $143.7 million, which compares to the estimate of $146.85 million. Narrows its FY10 sales guidance from $600-$640 million to $600-$620 million, vs. the cons. of $611.67 million.
iCad Inc. (Nasdaq: ICAD) 1.6% LOWER; reports Q2 loss of $0.02, 2 cents lower than the analyst estimate of $0.00. Revenue for the quarter was $6.1 million, which compares to the estimate of $6.6 million.
Tesoro (NYSE: TSO) 1.5% HIGHER; reports Q2 EPS of $0.30, ex-items, which may not compare than the analyst estimate of $0.17.
Lam Research (Nasdaq: LRCX) 1.3% HIGHER; reports Q4 EPS of $1.17, 10 cents better than the analyst estimate of $0.97. Revenue for the quarter was $695.3 million, which compares to the estimate of $656.48 million.
To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.
Create E-mail AlertRelated Categories
Special ReportsStocks Mentioned
+1.31
-1.32Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
